VMT-α-NET for neuroendocrine cancers and VMT01 for melanoma are both entering therapeutic trials under IND at leading US institutions. First melanoma patient screened and imaged with [203Pb]VMT01 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback